Your browser is no longer supported. Please, upgrade your browser.
EXAS Exact Sciences Corporation monthly Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Index- P/E- EPS (ttm)-2.20 Insider Own0.70% Shs Outstand150.16M Perf Week12.42%
Market Cap20.72B Forward P/E- EPS next Y-1.34 Insider Trans-19.23% Shs Float- Perf Month7.89%
Income-333.80M PEG- EPS next Q-0.30 Inst Own89.10% Short Float- Perf Quarter77.87%
Sales1.32B P/S15.69 EPS this Y55.40% Inst Trans3.88% Short Ratio5.52 Perf Half Y46.80%
Book/sh15.56 P/B8.54 EPS next Y54.00% ROA-8.00% Target Price150.43 Perf Year58.92%
Cash/sh8.23 P/C16.15 EPS next 5Y- ROE-13.80% 52W Range35.25 - 141.90 Perf YTD43.67%
Dividend- P/FCF- EPS past 5Y12.50% ROI-1.90% 52W High-6.36% Beta1.61
Dividend %- Quick Ratio6.00 Sales past 5Y244.80% Gross Margin75.50% 52W Low276.92% ATR6.27
Employees4110 Current Ratio6.40 Sales Q/Q86.70% Oper. Margin-33.40% RSI (14)65.82 Volatility4.85% 4.18%
OptionableYes Debt/Eq0.68 EPS Q/Q-368.20% Profit Margin-25.30% Rel Volume1.10 Prev Close130.67
ShortableYes LT Debt/Eq0.68 EarningsOct 29 AMC Payout- Avg Volume2.13M Price132.87
Recom1.50 SMA2010.26% SMA5016.92% SMA20051.44% Volume2,347,773 Change1.68%
Oct-29-20Downgrade UBS Buy → Neutral $125 → $140
Oct-28-20Downgrade Citigroup Buy → Neutral $120 → $140
Oct-08-20Resumed BTIG Research Buy $140
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Dec-03-20 06:30AM  
Nov-23-20 06:00AM  
Nov-14-20 12:05PM  
08:08AM  
Nov-13-20 11:11AM  
08:30AM  
Nov-08-20 09:06PM  
Nov-02-20 10:45AM  
06:00AM  
Oct-28-20 12:16PM  
10:24AM  
07:41AM  
Oct-27-20 04:35PM  
03:03PM  
02:09PM  
12:44PM  
11:26AM  
10:29AM  
10:25AM  
09:55AM  
08:19AM  
07:54AM  
07:14AM  
07:10AM  
07:01AM  
07:00AM  
Oct-26-20 09:01PM  
Oct-22-20 12:34PM  
Oct-12-20 09:00AM  
Oct-10-20 03:00PM  
Oct-09-20 06:00AM  
Oct-08-20 09:00AM  
Oct-07-20 06:11AM  
Oct-04-20 06:27AM  
Oct-01-20 02:22PM  
Sep-29-20 07:27AM  
Sep-28-20 08:53AM  
Sep-25-20 09:22AM  
Sep-24-20 03:37PM  
02:47PM  
02:35PM  
12:11PM  
Sep-21-20 04:27PM  
11:25AM  
Sep-17-20 06:00AM  
Sep-07-20 12:52PM  
Sep-01-20 04:05PM  
Aug-29-20 11:31AM  
Aug-01-20 04:03AM  
Jul-31-20 12:13PM  
11:13AM  
06:38AM  
Jul-30-20 06:30PM  
Jul-29-20 08:40AM  
Jul-23-20 12:32PM  
11:30AM  
Jul-17-20 08:00AM  
Jul-12-20 12:00PM  
Jul-08-20 07:45AM  
06:00AM  
Jun-16-20 03:09PM  
08:00AM  
Jun-05-20 11:31AM  
Jun-03-20 09:49AM  
01:15AM  
May-29-20 08:00AM  
May-26-20 06:00AM  
May-17-20 06:46AM  
May-12-20 03:10PM  
10:23AM  
May-11-20 10:19AM  
May-07-20 11:30AM  
10:09AM  
May-06-20 08:05PM  
03:00PM  
May-05-20 10:30AM  
10:16AM  
10:06AM  
08:45AM  
May-04-20 06:00AM  
May-03-20 07:36AM  
Apr-30-20 10:49AM  
Apr-29-20 12:34PM  
Apr-22-20 05:20AM  
Apr-08-20 05:51PM  
06:00AM  
Apr-02-20 09:00AM  
06:00AM  
Mar-26-20 05:45PM  
01:50PM  
Mar-24-20 09:44AM  
Mar-21-20 09:22AM  
Mar-19-20 06:00AM  
Mar-17-20 05:45PM  
03:18PM  
Mar-12-20 11:30AM  
Mar-04-20 07:37AM  
Feb-27-20 08:42AM  
Feb-25-20 08:28AM  
Feb-24-20 10:39PM  
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer. The company's pipeline products focuses on the research and development of enhancing Cologuard's performance characteristics, and blood or other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; Biocartis N.V.; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEODec 01Sale124.5630,5773,808,660857,518Dec 02 06:28 PM
Conroy Kevin TPresident and CEONov 02Sale121.1132,8193,974,738888,095Nov 03 04:49 PM
Conroy Kevin TPresident and CEOOct 01Sale103.5527,4252,839,829920,914Oct 02 05:54 PM
Hoof TorstenGeneral Manager, InternationalSep 24Option Exercise41.534,401182,7746,418Sep 28 04:33 PM
Hoof TorstenGeneral Manager, InternationalSep 24Sale80.004,401352,0802,017Sep 28 04:33 PM
Conroy Kevin TPresident and CEOSep 01Sale75.0319,9271,495,123948,339Sep 02 04:32 PM
Hoof TorstenGeneral Manager, InternationalAug 19Option Exercise43.401,51665,7949,981Aug 21 04:31 PM
Hoof TorstenGeneral Manager, InternationalAug 19Sale84.907,964676,1442,017Aug 21 04:31 PM
Hoof TorstenGeneral Manager, InternationalAug 17Option Exercise0.002,55108,465Aug 19 04:15 PM
Conroy Kevin TPresident and CEOAug 03Sale93.8025,1982,363,560968,266Aug 04 05:18 PM
Zanotti Katherine SDirectorJul 31Option Exercise8.5221,029179,16762,936Aug 04 04:54 PM
LEVANGIE DANIEL JDirectorJul 31Option Exercise9.309,86591,69924,881Aug 04 04:58 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Option Exercise21.686,638143,91275,861Aug 04 05:02 PM
Carey Thomas D.DirectorJul 31Option Exercise9.2415,620144,32952,492Aug 04 05:21 PM
Carey Thomas D.DirectorJul 31Sale94.0030,6202,878,28021,872Aug 04 05:21 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Sale93.8337,5003,518,77138,361Aug 04 05:02 PM
LEVANGIE DANIEL JDirectorJul 31Sale94.009,865927,31015,016Aug 04 04:58 PM
Zanotti Katherine SDirectorJul 31Sale94.0021,0291,976,72641,907Aug 04 04:54 PM
Doyle James EdwardDirectorJul 31Sale94.002,539238,66632,459Aug 04 04:45 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Sale95.588,746835,94369,223Jul 30 08:18 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 28Option Exercise94.8118,7501,777,68877,969Jul 30 08:18 PM
Zanotti Katherine SDirectorJul 28Sale96.131,164111,89541,907Jul 30 06:49 PM
Stenhouse MarkPresident, CologuardApr 03Sale56.6911,948677,33229,571Apr 06 04:41 PM
Stenhouse MarkPresident, CologuardApr 02Option Exercise0.0025,000041,519Apr 06 04:41 PM
Doyle James EdwardDirectorFeb 28Sale77.542,000155,08032,440Mar 03 07:20 PM
Conroy Kevin TPresident and CEOFeb 28Sale80.179,750781,658992,963Mar 02 07:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Sale80.172,383191,04558,578Mar 02 07:15 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Option Exercise0.005,025061,141Mar 02 07:15 PM
Conroy Kevin TPresident and CEOFeb 27Option Exercise0.0020,57501,002,713Mar 02 07:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Sale80.271,627130,59956,116Feb 28 04:37 PM
Stenhouse MarkPresident, CologuardFeb 27Sale80.271,05184,36416,519Feb 28 04:39 PM
Conroy Kevin TPresident and CEOFeb 27Sale80.2713,8751,113,746982,138Feb 28 04:36 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0029,3370996,013Feb 28 04:36 PM
Stenhouse MarkPresident, CologuardFeb 26Option Exercise0.003,262017,570Feb 28 04:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Option Exercise0.003,436057,743Feb 28 04:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 25Sale85.114,910417,89054,307Feb 26 05:13 PM
Conroy Kevin TPresident and CEOFeb 25Sale85.1118,1151,541,768966,676Feb 26 05:11 PM
Conroy Kevin TPresident and CEOFeb 24Option Exercise0.0034,3250984,791Feb 26 05:11 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Option Exercise0.009,300059,217Feb 26 05:13 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Option Exercise35.7717,356620,77637,550Feb 21 04:58 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Sale100.0027,3562,735,60010,194Feb 21 04:58 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 19Sale100.681,153116,0842,495Feb 20 05:55 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise0.003,64803,648Feb 20 05:55 PM
Hoof TorstenGeneral Manager, InternationalFeb 15Option Exercise0.002,09105,914Mar 27 04:15 PM
Cole G BradleyGeneral Manager - DiagnosticsJan 16Sale90.3010,000903,0008,653Jan 17 04:50 PM
Conroy Kevin TPresident and CEODec 16Option Exercise17.4811,440199,992950,466Dec 18 05:19 PM